Decisions that stand up to scrutiny
Independent decision reviews and operating systems for institutions and science-based ventures.
When the next commitment matters, I test the evidence, identify the binding constraint and give you a clear written basis for the decision.
Start with one decision. In 2–3 weeks, receive an independent recommendation of what to continue, change, fund or stop.
The outcome is determined between the components.
Science, market, IP, regulation, capital, team and execution are usually assessed separately. But complex technology commercialisation rarely fails because one element was ignored. It fails because the elements were combined in the wrong way, addressed in the wrong order or allowed to work against each other.
I examine where these factors reinforce, constrain or cancel each other out, which one is limiting progress, and in what sequence and proportion they should be addressed. The result is a decision architecture for the strongest defensible path to commercial success.
QUATISE® is the proprietary research and methodology basis behind each engagement. You receive independent judgement – as a decision-ready written record, or as a framework to implement.
What changes when I enter the decision
Institutions
The problem
Policies, initiatives and programmes can meet their targets while the outcomes they were designed for remain out of reach.
What I do
I evaluate evidence, incentives and delivery structures, then translate the findings into policy advice, initiative design and practical implementation.
What you receive
From independent evaluations to repeatable systems for execution: clear decision criteria, evidence gates, responsibilities and review routines.
Ventures
The problem
The science is progressing, but product, customer adoption and funding are pulling in different directions. The next investment may solve the wrong constraint.
What I do
I identify what is holding the venture back and connect technical evidence, commercial choices and capital into a clear sequence of decisions.
What you receive
From independent evaluations to repeatable systems for execution: a prioritised route forward, evidence milestones, decision gates and review routines.
Independent expertise. A clear point of view.
I’m Maria, an independent expert connecting science, commercial strategy and capital. Through Arise Innovations®, I help institutions and ventures turn complex evidence into decisions they can act on.
250+ cases assessed · 25+ programmes & ecosystems
€100M+ allocation exposure
My QUATISE® methodology is formally recognised as applied RD&I under OECD Frascati criteria.